HILLARY MCELROY: Open Payments
NPI 1972962777 · LUFKIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 11 payments from 9 companies in 2025. Trend: 2023 $514 · 2024 $38 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $49 |
| Astellas Pharma US Inc | 2 | $38 |
| Dexcom, Inc. | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| TOLMAR, INC. | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Veozah, Ozempic, Dexcom G6 Transmitter, Auvelity, FREESTYLE LIBRE 3, JARDIANCE, AUSTEDO XR, Wegovy.
Industry payments across TX — which companies pay providers there.
